Why malaria keeps spreading in Cameroon
Official title: Unraveling the Drivers of Persistent Malaria Transmission in Cameroon: A Systems Approach (REDIAL)
Funded at University of South Florida · NIH-11404823 · Data updated 2026-11-12
A team is mapping how and where malaria keeps spreading in Cameroon to help protect local children and families.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2026 |
| Award (this year) | $334,902 |
| NIH project number | 5U19AI181593-03 |
| Project ID | NIH-11404823 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living in the selected study communities in Cameroon—especially young children and household members with recent fevers—who can provide brief health information and small blood samples.
✕Less likely to help
People living outside the selected Cameroonian communities or in non-endemic areas are unlikely to be eligible or receive direct benefits from this project.
What this research studies
You would see teams working across Cameroon’s different ecological zones, collecting mosquitoes and testing blood from people with fever to find where infections continue. They will link information about mosquito species, parasite genetics, drug resistance, bed-net use, and local environment to pinpoint transmission hotspots. The project follows communities over time and combines local surveillance, household surveys, and laboratory analyses to build a detailed, place-by-place picture. Findings will be shared with local health programs to guide better-targeted control measures.
Why it matters
Potential benefit: If successful, this work could help target prevention and treatment to the places and people who need it most, reducing infections and child deaths.
How similar studies have gone: Integrated field, entomology, and genomic approaches have helped target interventions in other settings, but applying this broad systems approach across Cameroon’s diverse zones is relatively new.
Where this research is happening
-
University of South Florida
Tampa, United States Active
Researchers
- Principal investigator: Cui, Liwang — University of South Florida
- Study coordinator: Cui, Liwang
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.